Comparison of high‐dose (86.4 Gy) IMRT vs combined brachytherapy plus IMRT for intermediate‐risk prostate cancer
暂无分享,去创建一个
Y. Yamada | G. Cohen | M. Zelefsky | D. Spratt | Z. Zumsteg | X. Pei | P. Ghadjar | M. Kollmeier | W. Polkinghorn
暂无分享,去创建一个
Y. Yamada | G. Cohen | M. Zelefsky | D. Spratt | Z. Zumsteg | X. Pei | P. Ghadjar | M. Kollmeier | W. Polkinghorn